Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...
As groundbreaking studies continue to reshape the human immunodeficiency virus (HIV) landscape, emerging therapies and ...
Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...
Fostemsavir plus optimized background therapy was associated with improvements in immune biomarkers among HTE patients with MDR HIV infection.
The availability of such kidney transplants outside of the research setting could substantially improve organ availability ...
News Medical on MSN6d
Exclusion of indigenous voices hinders HIV progress in Latin AmericaIndigenous communities in Latin America say they are being excluded from the global HIV/AIDS response, leaving them without ...
Namibia has made significant strides in stemming the spread of HIV and AIDS through education and prevention. However, for people like Anna Engomba, the arrival of new, life-saving medication cannot ...
The national HIV prevalence was 16.3% among adults aged 15 years and older, translating to an estimated 7.4 million adults ...
The 2024 Sex Lives Report by LetsStopAIDS found 34% of youth diagnosed with an STI or HIV did not receive treatment — an ...
Natal, alarming gaps between scientific advancements and community behaviour persist. This article explores the critical need ...
News Medical on MSN3d
Sweden exceeds UNAIDS HIV goals but faces new challengesSweden has surpassed the UNAIDS 95-95-95 targets, with reduced HIV incidence and a steady increase in diagnosed and treated ...
Health NGO, Right to Care, highlights the urgent need for circumcision among boys aged 15 and older in KwaZulu-Natal to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback